Chitin, chitosan, and glycated chitosan regulate immune responses: The novel adjuvants for cancer vaccine

159Citations
Citations of this article
262Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development. © 2013 Xiaosong Li et al.

Cite

CITATION STYLE

APA

Li, X., Min, M., Du, N., Gu, Y., Hode, T., Naylor, M., … Chen, W. R. (2013). Chitin, chitosan, and glycated chitosan regulate immune responses: The novel adjuvants for cancer vaccine. Clinical and Developmental Immunology. https://doi.org/10.1155/2013/387023

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free